| | | 2019 | 51 |
| | | 2017 | 62 |
| | Huang, HZhu, JYao, MKim, TMYoon, DHCho, SGEom, HSLim, STYeh, SPSong, YKwong, YLKim, JSJin, JShi, YKim, HQing, MZhou, TGao, GDong, ZQi, MKim, WS | 2021 | 17 |
| Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelinesJournal:Radiotherapy & Oncology | Grégoire, VEvans, MLe, QTBourhis, JBudach, VChen, AEisbruch, AFeng, MGiralt, JGupta, THamoir, MHelito, JKHu, CHunter, KJohansen, JKaanders, JLaskar, SGLee, WMAMaingon, PMäkitie, AMicciche', FNicolai, PO'Sullivan, BPoitevin, APorceddu, SSkładowski, KTribius, SWaldron, JWee, JYao, MYom, MZimmermann, FCrau, C | 2018 | 157 |
| | | 2018 | 39 |
| | | 2019 | 26 |
| | YU, SJiao, JJJLuo, XLi, HWang, XZHANG, XYao, MZuo, JLIANG, WLU, M | 2023 | |
| | | 2010 | 176 |
| | Liang, LWong, CMYing, QFan, DNYHuang, SDing, JYao, JYan, MLi, JYao, MNg, IOLHe, X | 2010 | 173 |
| | | 2022 | |
| | | 2020 | 43 |
| | | 2019 | 28 |
| | Jing, YJia, DWong, CMNg, IOLZhang, ZLiu, LWang, QZhao, FLi, JYao, MWu, XHe, X | 2014 | 58 |
| | | 2021 | 14 |
| | Karam, IYao, MHeron, DEPoon, IKoyfman, SAYom, SSSiddiqui, FLartigau, ECengiz, MYamazaki, HHara, WPhan, JVargo, JALee, VHFFoote, RLHarter, KWLee, NYSahgal, ALo, SS | 2017 | 47 |
| | | 2018 | 60 |
| | Liu, LXu, YHe, MZhang, MCui, FLu, LYao, MTian, WBenda, CZhuang, QHuang, ZLi, WLi, XZhao, PFan, WLuo, ZLi, YWu, YHutchins, APWang, DTse, HFSchambach, AFrampton, JQin, BBao, XYao, HZhang, BSun, HPei, DWang, HWang, JEsteban, MA | 2014 | 159 |
| | | 2019 | 35 |
| | | 2008 | 163 |
